AZACITIDINE (Seton Pharmaceuticals)
Welcome to the PulseAid listing for the AZACITIDINE drug offered from Seton Pharmaceuticals. This Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Seton Pharmaceuticals |
| NON-PROPRIETARY NAME: | azacitidine for |
| SUBSTANCE NAME: | AZACITIDINE |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Nucleic Acid Synthesis Inhibitors [MoA],Nucleoside Metabolic Inhibitor [EPC] |
| ROUTE: | INTRAVENOUS; SUBCUTANEOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2017-05-17 |
| END MARKETING DATE: | 0000-00-00 |
AZACITIDINE HUMAN PRESCRIPTION DRUG Details:
| Item Description | AZACITIDINE from Seton Pharmaceuticals |
| LABELER NAME: | Seton Pharmaceuticals |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 100(mg/1) |
| START MARKETING DATE: | 2017-05-17 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 13925-523_7f99c736-ed7d-4c16-aa22-879cbdac11f1 |
| PRODUCT NDC: | 13925-523 |
| APPLICATION NUMBER: | ANDA207518 |
Other AZACITIDINE Pharmaceutical Manufacturers / Labelers:
